CEREBIOME® a new name for an established psychobiotic

CEREBIOME® (previously known as Probio’Stick®) is an innovative and unique psychobiotic formulation combining Lactobacillus helveticus Rosell®-52 and Bifidobacterium longum Rosell®-175 developed by the Rosell® Institute for Microbiome and Probiotics by Lallemand.

CEREBIOME® is the most documented psychobiotic on the Brain-Gut axis in the world as Lallemand has always been a pioneer in this major field of study.

Proven health benefits of CEREBIOME®

CEREBIOME® health effects are supported by five clinical and nine preclinical studies showing its beneficial impact on bidirectional communication between the brain and the gut through different pathways. Several mechanistic animal studies indicate the positive effects of the probiotic formula on behavioral models of anxiety and depression. Based on the growing knowledge of the Brain-Gut axis and on the documentation on the probiotic strains Lactobacillus helveticus Rosell®-52 and Bifidobacterium longum Rosell®-175, CEREBIOME® has clear mechanisms of action to explain its efficacy. CEREBIOME® improves the physical and psychological symptoms of stress and feelings of anxiety.  As supported by real-world evidence (long history of consumption) and clinical studies using the blend and the strains, CEREBIOME® is safe to use.

Breakthrough studies to cope with stress and moderate feelings of anxiety   

Such consistency of results is rare in this innovative field and subsequently much has been learned about the Brain-Gut axis by investigating the same probiotic formula through various research studies in different population groups and dosages. Two breakthrough clinical studies back CEREBIOME®. It was the first psychobiotic formula to scientifically demonstrate an improvement of gastrointestinal symptoms related to stress in healthy people, such as nausea, vomiting and abdominal discomfort, back in 2008.

A second pioneering study published in 2010, showed CEREBIOME® could help moderate general feelings of stress and anxiety, promoting a healthy mood balance for healthy active people experiencing mild to moderate stress caused by a life event [Messaoudi 2010]. In this randomized double-blind placebo-controlled study, psychological signs of occasional stress were evaluated using a range of validated psychological assessment scales. One month’s daily intake of CEREBIOME® significantly improved general signs and the subject’s ability to cope with everyday life stress. Moreover, those results were correlated with a biomarker for stress; a decrease in urinary free cortisol levels. CEREBIOME® provided digestive comfort and the general feeling of wellbeing among all participants subject to low to mild stress levels, suggesting the value of prophylactic intake.

CEREBIOME® continues to be the most documented psychobiotic in the world with more than a decade of evidence after its first proven effects on the Brain-Gut axis.